Skip to main content
CRONEX.CO.,LTD logo

CRONEX.CO.,LTD — Investor Relations & Filings

Ticker · 215570 ISIN · KR7215570003 KO Professional, scientific and technical activities
Filings indexed 177 across all filing types
Latest filing 2025-12-19 Proxy Solicitation & In…
Country KR South Korea
Listing KO 215570

About CRONEX.CO.,LTD

http://www.cronex.co.kr/

CRONEX.CO.,LTD. is a Contract Research Organization (CRO) that provides research and development services for the pharmaceutical and biomaterial industries. The company focuses on the supply and manufacture of biological species and bio-tissue materials for medical research. Its key offerings include non-clinical CRO services centered on the use of minipigs, particularly for xenograft research and development. The company also engages in the development of medicines and raw materials, and provides services related to transgenic technologies.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (주주총회소집공고) for Cronex Co., Ltd. It details the meeting agenda, including the appointment of a director and an auditor, and provides background information on the candidates and the company's business operations. This type of document is specifically designed to provide shareholders with the necessary information to vote at a general meeting, which falls under the category of Proxy Solicitation & Information Statement.
2025-12-19 Korean
주요사항보고서(타법인주식및출자증권양수결정)
Capital/Financing Update Classification · 95% confidence The document is a detailed report about the decision to acquire shares and equity securities of another company, including specifics about the transaction, parties involved, valuation, payment methods, and related financial data. It is addressed to regulatory bodies (Financial Services Commission and Korea Exchange) and includes detailed financial and transaction information. The document is not an announcement of a report publication but a substantive disclosure about a capital transaction involving third-party allotment of new shares and acquisition of significant shareholding. This fits the definition of a Capital/Financing Update (CAP), as it provides updates on company fundraising, financing activities, or capital structure changes.
2025-10-31 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a detailed report about a capital increase through a third-party allotment (유상증자결정) by Cronex Co., Ltd. It includes specifics such as the number and type of new shares, issuance price, purpose of funds, board resolution details, and related financial evaluations. The presence of terms like '유상증자 결정' (decision on paid-in capital increase), detailed share issuance data, and references to board resolutions and fund usage clearly indicate this is a capital/financing update. The document is not an announcement of a report publication but the actual disclosure of the capital increase decision and details. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-10-31 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is titled '기업설명회(IR) 개최 결과' which translates to 'Investor Relations (IR) Meeting Results'. It details the date, time, location, attendees, main contents (company introduction, management status and outlook, Q&A), and confirmation by regulatory bodies. The document is a summary of an investor presentation event rather than the presentation slides or detailed financial data itself. The length is short (902 characters), and it reports on the occurrence and results of an IR meeting. This fits the category of an Investor Presentation (IP) or a report about it. Since it is a summary of the event and contents, it aligns best with Investor Presentation (IP).
2025-10-27 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is an announcement of an upcoming investor relations event (기업설명회(IR) 개최), specifying the date, time, location, participants, purpose, and method of the event. It does not contain any financial data, analysis, or detailed presentation materials itself. The document also states that the IR materials will be posted later on the stock exchange disclosure system. Given the short length (1044 characters) and the nature of the content as an event announcement rather than the event materials or report, this fits the category of an Investor Presentation announcement. However, since it is only announcing the event and not providing the presentation itself, the best fitting category is Regulatory Filings (RNS) as a general announcement, because it does not contain the actual presentation or report. Confidence is high due to clear event announcement characteristics and absence of financial data or report content.
2025-10-10 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a notification regarding the appointment, dismissal, or mid-term resignation of an outside director (사외이사) of a company named 크로넥스 주식회사. It includes details such as dates, names, and changes in the board composition. There is no financial data, no mention of financial results, reports, or presentations. The document is a formal announcement to regulatory bodies (Financial Services Commission/Korea Exchange) about changes in board members. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short and focused solely on director changes, confirming this classification with high confidence.
2025-09-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.